Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05629572 · ClinicalTrials.gov registry record
Abbott i-STAT High Sensitivity Troponin I Study
A clinical trial, sponsored by Abbott Point of Care.
- Completed
- Registry status
- 3,697
- Enrollment target
NCT05629572: Completed study, sponsored by Abbott Point of Care.
NCT05629572 is a clinical trial that has completed, run by Abbott Point of Care. The registered enrollment target is 3,697 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05629572 has completed, sponsored by Abbott Point of Care.
- COMPLETED
- Registry status
- 3,697 participants
- Enrollment target
Study Summary
The goal of this observational multi-center study is to evaluate the clinical performance of the i-STAT hs-TnI test (i-STAT High Sensitivity Troponin I) using the investigational i-STAT hs-TnI cartridge for the proposed intended use as an aid in the diagnosis and treatment of myocardial infarction (MI). The cartridge measures cardiac troponin I (cTnI) in whole blood or plasma samples using the i-STAT 1 Analyzer or i-STAT Alinity Instrument. Subjects presenting to the emergency department (ED) with chest discomfort or equivalent ischemic symptoms suggestive of Acute Coronary Syndrome (ACS) who are enrolled in this study will be asked to provide blood samples for testing.
Primary Outcome
Performance metrics calculated using adjudicated outcomes with the hs-TnI test results.
Interventions
- DIAGNOSTIC_TEST i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,697 participants |
| Start Date | 2022-11-02 |
| Est. Completion | 2024-03-11 |
What the finished NCT05629572 record still lists
NCT05629572 is an observational study that tracks outcomes without assigning an intervention. Its 3,697 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity is the first listed.
NCT05629572 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05629572 about?
NCT05629572 is a clinical study titled "Abbott i-STAT High Sensitivity Troponin I Study". The goal of this observational multi-center study is to evaluate the clinical performance of the i-STAT hs-TnI test (i-STAT High Sensitivity Troponin I) using the investigational i-STAT hs-TnI cartridge for the proposed intended use as an aid in the diagnosis and treatment of myocardial infarction (...
What is the current status of trial NCT05629572?
This trial is currently completed. The enrollment target is 3,697 participants. The study started on 2022-11-02. Estimated completion is 2024-03-11.
What interventions are being tested in trial NCT05629572?
The interventions under investigation include: i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05629572?
This trial is sponsored by Abbott Point of Care, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06401863 · 3,691 participants · NA
Shared Decision for Drug Interactions in Oral Anticoagulation
- NCT06784960 · 3,689 participants · NA
Communication Strategies to Increase HPV Vaccination Intention
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI